Zydus

Zydus Cadila, commonly known as Zydus, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India. It was founded in 1952 by Indravadan A. Modi and is one of the leading drug manufacturers in the country. The company is part of the Cadila Healthcare Limited group, which is publicly listed on the Indian stock exchanges.

Zydus operates in various segments of the pharmaceutical industry, including formulations, biotechnology, and active pharmaceutical ingredients (APIs). The company has a strong presence in both domestic and international markets, with its products available in over 75 countries across the globe. Zydus's portfolio includes a wide range of medicines across therapeutic areas such as cardiology, diabetology, gastroenterology, and more.

The company is known for its significant investments in research and development (R&D). Zydus has several state-of-the-art R&D facilities where it conducts extensive research to develop new and innovative drugs. The company has successfully launched several patented drugs and has a robust pipeline of new molecules in various stages of development.

Zydus is also involved in several philanthropic activities through its foundation, the Zydus Cadila Foundation. The foundation focuses on areas such as healthcare, education, and rural development, aiming to improve the quality of life in underprivileged communities.

In recent years, Zydus has expanded its operations through strategic acquisitions and partnerships. The company has acquired several pharmaceutical firms to strengthen its market position and broaden its product portfolio. Zydus continues to be a key player in the Indian pharmaceutical industry, contributing significantly to the healthcare sector both nationally and internationally.